Evidence Shows Effectiveness of Early Sotagliflozin Treatment

Adding the diabetes drug sotagliflozin (Zynquista) early in treatment of patients with type 2 diabetes was effective in reducing heart failure, heart attack, and stroke in the patients studied, according to trial results presented at the American Diabetes Association symposium. Read more

Posted in Type II Drugs